Skip to content
Luna Metabolic
Menu

Evidence review

GLP-1 Medication and PCOS: What Women Should Know

How GLP-1 medicines target the insulin resistance behind PCOS weight — and the questions to ask a provider about tirzepatide, labs and androgens.

By The Luna Editorial Team, Women's Metabolic Health Desk

Why GLP-1 medicines are relevant to PCOS

Polycystic ovary syndrome is, at its core, a metabolic condition as much as a reproductive one. Insulin resistance is a central driver for most women with PCOS, feeding higher androgen levels, irregular cycles and stubborn weight gain3. GLP-1 receptor agonists were designed to improve exactly this machinery — they slow gastric emptying, blunt appetite and improve the body's response to insulin — which is why they have become such a focus for women whose PCOS weight will not shift with diet and exercise alone4.

What the evidence shows

The large obesity trials that put these drugs on the map were not PCOS-specific, but they enrolled many women and are the best evidence for the medications themselves. In the STEP 1 trial, once-weekly semaglutide produced a mean body-weight reduction of roughly 15% over 68 weeks1. Tirzepatide — a dual GIP/GLP-1 agonist — went further in SURMOUNT-1, with mean reductions around 20% at the highest dose2. Because insulin resistance is so central to PCOS, many women and their clinicians are specifically interested in tirzepatide's metabolic effect, which is one reason we weight access to both molecules heavily in our Luna Fit Score.

What to ask a provider

The right provider for PCOS does more than mail a vial. Ask whether a licensed clinician reviews your history and runs or interprets labs; whether both semaglutide and tirzepatide are available so you are not locked into one molecule; and how titration and side effects are supported over the first months. These are the factors that separate a genuine women's-metabolic program from a prescription vending machine — and they are exactly what our top-ranked partner, CoreAge Rx, is scored on.

The cautions that matter for women

GLP-1 medicines are not appropriate during pregnancy or while trying to conceive, and — notably — improving insulin sensitivity can restore ovulation in women with PCOS, which can make pregnancy more likely than expected3. They can also affect absorption of oral medications. None of this is a reason to avoid treatment; it is a reason to have it managed by a clinician who understands your hormones and goals. This guide is educational only and not medical advice.

Frequently asked questions

Is tirzepatide or semaglutide better for PCOS?

There is no PCOS-specific head-to-head, but tirzepatide produced larger average weight loss in obesity trials and its dual mechanism draws interest given the insulin resistance behind PCOS. The right choice depends on your history, tolerance and clinician's judgment.

Can GLP-1 medication help my cycles or fertility?

By reducing weight and improving insulin sensitivity, GLP-1 treatment can help restore more regular ovulation in some women with PCOS. That also means fertility can increase unexpectedly, so contraception and pregnancy planning should be discussed with your clinician.

References

  1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2032183
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2206038
  3. American College of Obstetricians and Gynecologists (2023). Polycystic Ovary Syndrome (PCOS): patient FAQ. ACOG. https://www.acog.org/womens-health/faqs/polycystic-ovary-syndrome-pcos
  4. Endocrine Society (2022). Polycystic Ovary Syndrome — Endocrine Library. Endocrine Society. https://www.endocrine.org/patient-engagement/endocrine-library/pcos

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Continue reading